Breadcrumb Home Studies Studies Search Filter Research Area AllComplications & ComorbiditiesCureTreatmentTuberculosis Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentParticipants Off Study and Primary Analysis CompletedPending Sort Study Number AscStudy Number Desc Submit Search Showing 12 studies. A5241: Identifying Salvage Regimen w/ & w/o NRTIs Using cPSS and New Agents in the US DAIDS Number 10395 Research Area Antiretroviral Strategies Study Status Concluded P1096: Phase 1 Study of Live Attenuated Recombinant (cp) 45 Human Parainfluenza Type 3 Vaccine DAIDS Number 11796 Research Area Vaccine Study Status Concluded P1094: Evaluation of the use 3TC DAIDS Number 11769 Research Area Other Study Status Concluded P1089: Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Chldren/youth DAIDS Number 11670 Research Area Other Study Status Concluded P1088: H1N1 INFLUENZA VACCINE IN HIV-INFECTED CHILDREN AND ADOLESCENTS DAIDS Number 10840 Research Area Other Study Status Concluded P1085: Human Papilloma Virus (HPV) Type-Specific Antibody DAIDS Number 10826 Research Area Other Study Status Concluded P1084s: Maternal Infant TDF Toxicity Safety DAIDS Number 10790 Research Area Therapeutics Study Status Closed to Follow Up P1079: PHARMACOLOGY OF ARTEMISININ-BASED ANTIMALARIAL THERAPY DAIDS Number 10765 Research Area Other Study Status Concluded P1076: Impact of Oral Alendronate Therapy on BMD in HIV-Infected Children/Adolescents DAIDS Number 10669 Research Area Complications & Comorbidities Study Status Concluded P1072: Safety and Immunogenicity of a Live, Attenuated, Rotavirus Vaccine (RotaTeq™) in HIV-1 Infected and Uninfected Children Born to HIV-1 Infected Mothers DAIDS Number 10638 Research Area Complications & Comorbidities Study Status Concluded Pagination Current page 1 Page 2 Next page Next
A5241: Identifying Salvage Regimen w/ & w/o NRTIs Using cPSS and New Agents in the US DAIDS Number 10395 Research Area Antiretroviral Strategies Study Status Concluded
P1096: Phase 1 Study of Live Attenuated Recombinant (cp) 45 Human Parainfluenza Type 3 Vaccine DAIDS Number 11796 Research Area Vaccine Study Status Concluded
P1089: Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Chldren/youth DAIDS Number 11670 Research Area Other Study Status Concluded
P1088: H1N1 INFLUENZA VACCINE IN HIV-INFECTED CHILDREN AND ADOLESCENTS DAIDS Number 10840 Research Area Other Study Status Concluded
P1085: Human Papilloma Virus (HPV) Type-Specific Antibody DAIDS Number 10826 Research Area Other Study Status Concluded
P1084s: Maternal Infant TDF Toxicity Safety DAIDS Number 10790 Research Area Therapeutics Study Status Closed to Follow Up
P1079: PHARMACOLOGY OF ARTEMISININ-BASED ANTIMALARIAL THERAPY DAIDS Number 10765 Research Area Other Study Status Concluded
P1076: Impact of Oral Alendronate Therapy on BMD in HIV-Infected Children/Adolescents DAIDS Number 10669 Research Area Complications & Comorbidities Study Status Concluded
P1072: Safety and Immunogenicity of a Live, Attenuated, Rotavirus Vaccine (RotaTeq™) in HIV-1 Infected and Uninfected Children Born to HIV-1 Infected Mothers DAIDS Number 10638 Research Area Complications & Comorbidities Study Status Concluded
